136 related articles for article (PubMed ID: 2452773)
1. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.
Zurawski VR; Knapp RC; Einhorn N; Kenemans P; Mortel R; Ohmi K; Bast RC; Ritts RE; Malkasian G
Gynecol Oncol; 1988 May; 30(1):7-14. PubMed ID: 2452773
[TBL] [Abstract][Full Text] [Related]
2. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
[TBL] [Abstract][Full Text] [Related]
3. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
4. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
6. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
7. Epithelial ovarian carcinoma of low malignant potential.
Darai E; Teboul J; Walker F; Benifla JL; Meneux E; Guglielmina JN; Pennehouat G; Renolleau C; Sebban E; Madelenat P
Eur J Obstet Gynecol Reprod Biol; 1996 Jun; 66(2):141-5. PubMed ID: 8735736
[TBL] [Abstract][Full Text] [Related]
8. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.
Bast RC; Siegal FP; Runowicz C; Klug TL; Zurawski VR; Schonholz D; Cohen CJ; Knapp RC
Gynecol Oncol; 1985 Sep; 22(1):115-20. PubMed ID: 2410329
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum CA-125 levels in borderline tumors of the ovary.
Rice LW; Lage JM; Berkowitz RS; Goodman A; Muto MG; Knapp RC; Bell DA
Gynecol Oncol; 1992 Aug; 46(2):226-9. PubMed ID: 1500026
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
Malkasian GD; Knapp RC; Lavin PT; Zurawski VR; Podratz KC; Stanhope CR; Mortel R; Berek JS; Bast RC; Ritts RE
Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
[TBL] [Abstract][Full Text] [Related]
11. CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary.
Einhorn N; Knapp RC; Bast RC; Zurawski VR
Acta Oncol; 1989; 28(5):655-7. PubMed ID: 2590540
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma.
Mann WJ; Patsner B; Cohen H; Loesch M
J Natl Cancer Inst; 1988 Apr; 80(3):208-9. PubMed ID: 3162284
[TBL] [Abstract][Full Text] [Related]
13. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
16. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
Zurawski VR; Broderick SF; Pickens P; Knapp RC; Bast RC
Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
[TBL] [Abstract][Full Text] [Related]
17. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
Knauf S; Anderson DJ; Knapp RC; Bast RC
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum CA-125 levels in early stage ovarian cancer.
Patsner B
Eur J Gynaecol Oncol; 1990; 11(5):319-21. PubMed ID: 2097148
[TBL] [Abstract][Full Text] [Related]
20. Elevation of multiple serum markers in patients with stage I ovarian cancer.
Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
